Healthy Aging Health Center
Convertibles Hazardous to Your Hearing?
Oct. 6, 2009 -- Convertible lovers who take to the open road with the top down may be risking hearing damage, according to a new study out of the U.K.
"If you are exposed for long periods above 85 decibels [of sound], you have the potential for hearing loss," says Philip Michael, MD, an ear-nose-throat surgeon at Worcestershire Royal Hospital in Worcestershire, U.K., and the study's lead author. In his study, he found that the noise level with the top down was higher than 85 decibels. "The maximum noise was at 70 miles per hour and that was 89 decibels. It has the potential for causing long-term hearing loss.''
To put those decibel levels in context, a normal conversation is about 60 decibels; a rock concert is about 115 decibels.
Michael is slated to present the study -- which was funded by the Worcestershire Royal Hospital -- at the American Academy of Otolaryngology-Head and Neck Surgery annual meeting in San Diego.
Testing Noise Exposure
Previous research done by others about motorcyclists' noise exposure, coupled with his own love of convertibles, prompted the study, Michael tells WebMD. Motorcycle riders tend to wear earplugs, he finds.
But the topic of noise exposure to convertible drivers has not been studied much, he says. So Michael solicited convertible-driving friends who donated six cars. Another car -- a Morgan plus 4 Roadster -- was borrowed from the car company. Then Michael and his co-researchers measured the noise exposure to a single driver driving seven different convertibles at 50, 60, and 70 miles per hour.
The cars tested were:
- Toyota MR2
- Mazda Miata MX5
- Audi A4 Cabriolet
- Morgan plus 4 Roadster
- Porsche 997 Carrera
- Aston Martin V-8 Vantage
- Bentley convertible
"We measured the nose by the driver's ear,'' Michael says. Noise by the driver's right ear -- the roadside ear, in the U.K. -- was measured for one minute with a sound level meter as the cars were driven at 50, 60, and 70 mph with the windows lowered and the top down. They also measured the noise exposure with the windows raised but the top still down when the cars were driven at 70 miles per hour.
When driven at 70 mph, the noise averaged 89 decibels, Michael found, with not much difference among the cars, which ranged from moderately priced to extravagantly priced. ''The car price didn't matter," he says.
The size of the sample was too small to perform statistical analysis, Michael notes, but he did find a general trend toward increased, although minimal, noise exposure with speed.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

